Anti-VEGF injections (IVI) are used in several retinal disorders, including exudative age-related macular degeneration (nAMD)3, diabetic retinopathy (DR)4, retinal vein occlusions (RVO)5,6, and secondary choroidal neovascularization (CNV)1,7. Here, VEGFA is linked to retinal vein occlusion.